Life Scintel

Market Need
One of the big challenges facing many nations is effectively and efficiently managing healthcare of an ever increasingly ageing population. It is estimated that the worldwide cost of dementia equates to more than 1% of global GDP, made up of social care, unpaid care by relatives and medical bills. Dementia is considered by many as the most significant health and social crisis of the 21st century, and it is apparent that dementia diagnosis and care need to be vastly improved.

Our Solution
Life Scintel AB has developed DMSSTM (Dementia Management and Support System), an interactive software that aids the dementia diagnostic process. It provides support for physicians in their diagnostic reasoning and choice of interventions when meeting new patients with a suspected dementia disease. This is accomplished by providing advice tailored to an individual patient, continuing medical education in daily practice, easy access to clinical guidelines at the point of care and a common ground for team work and consultations/cooperation between levels of care in the dementia domain. DMSS is currently provided in English, Swedish, Korean, Japanese and Chinese versions

Competitive Advantages
DMSSTM is a unique and user interactive software which provides the practitioner with step by step rationale, diagnostic guidelines and decision advice tailored to an individual patient’s presenting symptoms. Use of DMSSTM will result in overall reduction in the care burden and health care costs through eartier diagnosis and treatment, improved clinical management, excellent planning for the individual patient and societal planning of dementia care.